References
- Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117:1167–1174.
- Beyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006;108:804–811.
- Darrasse-Jeze G, Deroubaix S, Mouquet H, . Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med 2009;206:1853–1862.
- Giannopoulos K, Schmitt M, Kowal M, . Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep 2008;20:677–682.
- Gobert M, Treilleux I, Bendriss-Vetmare N, . Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res 2009;69:2000–2009.
- Carreras J, Lopez-Guillermo A, Fox BC, . High number of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 2006; 108:2257–2264.
- Alvaro T, Lejeune M, Salvado MT, . Outcome in Hodgkin's lymphoma can be predicted from the presence of the accompanying cytotoxic and regulatory T cells. Clin Cancer Res 2005;11:1467–1473.
- Prabhala RH, Neri P, Bae JE, . Dysfunctional T regulatory cells in multiple myeloma. Blood 2006;107:301–304.
- Lad DP, Varma S, Varma N, . Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias. Leuk Lymphoma 2013;54;1012–1019.
- D’Arena G, Laurenti L, Minervini MM, . Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlate with progressive disease. Leuk Res 2011;35:363–368.
- Pepper C, Majid A, Lin TT, . Defining the prognosis of early stage chronic lymphocytic leukemia patients. Br J Haematol 2012;156:499–507.
- D’Arena G, D’Auria F, Simeon V, . A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia. Am J Hematol 2012;87:628–631.
- Beyer M, Clasen S, Endl E, . Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. Clin Dev Immunol 2011;2011:1–12.
- Tiemessen MM, Mitchell TJ, Hendry L, . Lack of suppressive CD4 + CD25+ FOXP3 + T cells in advanced stages of primary cutaneous T-cell lymphoma. J Invest Dermatol 2006;126:2217–2223.
- Ramsay AG, Clear AJ, Fatah R, . Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer. Blood 2012;120:1412–1421.